Company
Personalis
Transforming the Active Management of Cancer
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Our advanced ctDNA technologies enable the most sensitive detection with cancer insights from molecular residual disease to therapy selection.
Loading relationship preview